Germany· DE-A57-3aaaea3a54e9b9a9
Metypred Forte
A medicinal product containing methylprednisolone sodium succinate, registered in Germany by Galenpharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Methylprednisolone Sodium Succinate
- Manufacturer
- Galenpharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylprednisolone sodium succinate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethylprednisolone sodium succinateDr. Reddy's Laboratories Inc
- FinlandMethylprednisolone OrionOrion Corporation
- BelgiumMethylprednisolone Teva 1000 mgTeva Pharma Belgium
- United KingdomMethylprednisolone sodium succinate 125mg powder and solvent for solution for injection vialsPfizer Ltd
- CzechiaSOLU-MEDROLPfizer, spol. s r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Solu-Medrol
- Bulgaria · Метилпреднизолон Чайкафарма
- Czechia · Solu-Medrol
- Spain · Urbason
- France · Methylprednisolone Hikma
- United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
- Hungary · Metilprednizolon Teva
- Italy · Cortrium, Lisamethyle
- Poland · Meprelon
- Portugal · Metilprednisolona Hikma
- Slovakia · Metylprednizolón Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6293ea8-ee2c-4db3-a714-87dd8d44b06c GET /v1/drugs/c6293ea8-ee2c-4db3-a714-87dd8d44b06c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Methylprednisolone Sodium Succinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about methylprednisolone sodium succinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.